Abstract PS2-04-09: Impact of prior treatment exposure and clinical-pathological factors on response and survival with Sacituzumab govitecan in advanced breast cancer: a consecutive real-world series
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: C. Gullotta, S. Cobo, B. Walbaum, M. Bergamino, R. Gómez-Bravo, O. Martínez-Sáez, F. Schettini, E. Segui, I. García-Fructuoso, T. Pascual, N. Chic, M. González-Rodríguez, G. Riu, E. Carcelero, A. Rodríguez-Hernández, E. Sanfeliu, P. Galván, M. Muñoz, M. Vidal, A. Prat, F. Braso-Maristany, B. Adamo
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130697500
Cites:
Cited by:
Related to:
